Brigatinib CAS 1197953-54-0 Kuchena > 99.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. ndiyo inotungamira mugadziri weBrigatinib (AP-26113) (CAS: 1197953-54-0) ine mhando yepamusoro.Ruifu Chemical inogona kupa kutumirwa kwepasirese, mutengo wemakwikwi, sevhisi yakanakisa, idiki uye yakawanda huwandu huripo.Tenga Brigatinib,Please contact: alvin@ruifuchem.com
Chemical Name | Brigatinib |
Mashoko anoreva zvakafanana | AP26113;AP-26113;5-Chloro-N4-[2-(Dimethylphosphinyl)phenyl]-N2-[2-Methoxy-4-[4-(4-Methyl-1-Piperazinyl)-1-Piperidinyl]phenyl]-2,4-Pyrimidinediamine |
Stock Status | MuStock, Commercial Production |
Nhamba yeCAS | 1197953-54-0 |
Molecular Formula | C29H39ClN7O2P |
Molecular Weight | 584.09 g/mol |
Melting Point | >203 ℃(Zvita) |
Density | 1.31±0.10 g/cm3 |
COA & MSDS | Available |
Origin | Shanghai, China |
Brand | Ruifu Chemical |
Items | Zvinotsanangurwa | Results |
Chitarisiko | Ichena kusvika kuOff-White Powder | Zvinoenderana |
Kuchena / Analysis Method | >99.0% (HPLC) | 99.26% |
Max.Kusachena Kumwechete | <1.00% | 0.25% |
Kurasika paKuomesa | <1.00% | 0.27% |
Infrared Spectrum | Zvinoenderana NeChimiro | Zvinoenderana |
1H NMR Spectrum | Zvinoenderana NeChimiro | Zvinoenderana |
Mhedziso | Chigadzirwa chakaedzwa uye chinoenderana nezvakapihwa |
Package:Fluorinated Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mudziyo wakavharwa zvakasimba uye chengeta muimba inotonhorera, yakaoma uye ine mhepo yakanaka kure nezvinhu zvisingaenderani.Dzivirira kubva kuchiedza uye unyoro.
KutumiraKuendesa kupasirese nemhepo, neFedEx / DHL Express.Ipa kutumirwa nekukurumidza uye kwakavimbika.
Kutenga sei?Please contactDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Makore 15 Oupenyu?Tine makore anopfuura 15 ane ruzivo mukugadzira uye kutumira kunze kwemhando dzakasiyana-siyana dzepamusoro dzemishonga yepakati kana makemikari akanaka.
Main Markets?Tengesa kumusika wepamba, North America, Europe, India, Korea, Japan, Australia, nezvimwe.
Zvakanakira?Hunhu hwepamusoro, mutengo unokwanisika, masevhisi ehunyanzvi uye rutsigiro rwehunyanzvi, kuendesa nekukurumidza.
HunhuSimbiso?Strict quality control system.Midziyo yehunyanzvi yekuongorora inosanganisira NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, nezvimwe.
Samples?Zvigadzirwa zvakawanda zvinopa mahara emahara ekuongorora kwemhando, mutengo wekutumira unofanirwa kubhadharwa nevatengi.
Factory Audit?Factory audit inogamuchirwa.Ndapota itai nguva isati yasvika.
MOQ?Hapana MOQ.Kurongeka kudiki kunogamuchirwa.
Delivery Nguva? Kana mukati me stock, mazuva matatu kutumirwa anovimbiswa.
Transportation?Ne Express (FedEx, DHL), neMhepo, neGungwa.
Zvinyorwa?Mushure mekutengesa sevhisi: COA, MOA, ROS, MSDS, nezvimwe zvinogona kupihwa.
Custom Synthesis?Inogona kupa echinyakare synthesis masevhisi kuti aenderane nezvinodiwa zvako zvekutsvagisa.
Payment Terms?Proforma invoice inozotumirwa kutanga mushure mekusimbisa kurongeka, yakavharirwa ruzivo rwedu rwebhangi.Kubhadhara neT/T (Telex Transfer), PayPal, Western Union, nezvimwe.
Brigatinib (AP-26113) (CAS: 1197953-54-0) inoferefeta diki-morekuru rakanangana nekurapa cancer irikudziridzwa neARIAD Pharmaceuticals, Inc. Brigatinib mushonga unoshandiswa kurapa cancer inodzvanya epidermal growth factor receptor (EGFR) uye anaplastic lymphoma kinase (ALK).Brigatinib inosarudza agonist inopesana nekusiyana kweEGFR kusiyana nemhando dzomusango.Mushonga uyu unoratidzawo kusarudzika kunopesana neiyo ALK-EML4 fusion gene, inova chinhu chakakosha pakugadziriswa kweanogona kubatwa nemapapu parenchyma.Brigatinib inonyorerwa varwere vane majini chaiwo asina kujairika uye kana isiri-diki cell kenza yemapapu (NSCLC) isinga pindure kune manejimendi nemimwe mishonga.Brigatinib inorongedzerwa sekinase inhibitor, iyo maitiro ekuita anosanganisira kudzvanyirira kuita kwemapuroteni asina kujairika anowedzera kuwanda kwekenza maseru.
Brigatinib (CAS: 1197953-54-0) inonyorerwa varwere vane mafomu chaiwo eNSCLC akapararira kune zvikamu zvakasiyana-siyana zvemuviri muvanhu vakamborapwa nemimwe mishonga yekenza yakadai seCrizotinib, uye mamiriro avo akawedzera kuipa. kana kuti dzinoratidza zviratidzo zvishoma zvekuvandudzwa.Iri kunyanya pasi pekuferefetwa kwekurapa kwayo pane isiri-diki cell kenza yemapapu (NSCLC) uko ALK inoshandiswa uye kuchinja kweEGFP kunowanzoitika.
Brigatinib (AP-26113) (CAS: 1197953-54-0) inhibitor yechizvarwa chitsva che tyrosine kinase, inoratidza kushanda kwakakosha muALK+ metastatic NSCLC.Musi waNyamavhuvhu 30, 2016, United States FDA yakapa bugtinib senzira yekurapa uye isingawanzo mushonga weALK+NSCLC mune varwere vakagadzira kana vasingakwanisi kushivirira Crizotinib, chizvarwa chekutanga ALK+NSCLC kurapwa.Ipa iyo yekutanga kunyorwa kwechikumbiro chekuongorora uye bvumidza iyo data rekunyorera kuti riunzwe pane inotenderera.Iyo FDA yakabvumidza Bugtinib muna Kubvumbi 28, 2017, pasi pezita rekutengesa Alunbrigtm.